Overview

Basal Insulin in the Management of Patients With Diabetic Ketoacidosis (DKA)

Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The study is a multicenter, randomized controlled trial to compare the safety and efficacy of insulin analogs and human insulins both during acute intravenous treatment and during the transition to subcutaneous insulin in patients with diabetic ketoacidosis (DKA).
Phase:
Phase 4
Details
Lead Sponsor:
Emory University
Collaborator:
Sanofi
Treatments:
Insulin
Insulin Glargine
Insulin, Globin Zinc
Insulin, Isophane